Skip to main content
OpenTrials
Completed

NCT Number: NCT04447638

Percutaneous Tracheostomy With COVID-19

Coronavirus disease 2019 (COVID-19) has brought about a requirement of intensive care and mechanical ventilation for a significant portion of patients. Percutaneous tracheostomy is performed in order to reduce the complications that may develop due to prolonged endotracheal intubation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tracheostomy

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Canakkale Onsekiz Mart University

Çanakkale, 17020, Turkey (Türkiye)

About this study

Different methods are needed for situations in which the potential for producing aerosols is high, such as intubation and tracheostomy. One of these methods is the aerosol box.To share our experiences of percutaneous tracheostomy performed with aerosol box in COVID-19 patients. Patients who underwent percutaneous tracheostomy between March 2020 and June 2020 in the pandemic intensive care unit were evaluated retrospectively.The study is designed as a clinical trial study. This study was performed in faculty of medicine hospital's intensive care unit which is located in Canakkale province Turkey.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • who underwent percutaneous tracheostomy with COVID-19(+)

Exclusion criteria

  • Patients who do not give informed consent or do not want to participate in the study
  • Coagulopathy, thrombocytopenia

Treatment and study plan

Tracheostomy with aerosol box in COVID-19 positive patients

Procedure

Patients who underwent percutaneous tracheostomy with aerosol box in COVID-19 positive patients. The patients age, gender, hospitalization diagnosis, number of intubated days, anesthetic agents used during the procedure, neck ultrasonography data before and during the procedure, and complications were recorded.

Primary outcomes

  1. Complications observed in the cases in which we applied percutaneous tracheostomy with aerosol box

    Time frame: During the procedure

    Complications

Sponsors and collaborators

Lead sponsor

Çanakkale Onsekiz Mart University

Other

Registry information

Official study title

Percutaneous Tracheostomy With Aerosol Box in COVID-19 Positive Patients in Intensive Care Unit: a Clinical Trial

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jun 25, 2020
Registry last updated
Sep 24, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.